Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Jen Tsai

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|August 12, 2016
BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid LeukemiaLi-Tzong Chen, Chiung-Tong Chen, Weir-Torn Jiaang, et al.
The Oncologist|June 21, 2024
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 studyHui-Jen Tsai, Shih-Hung Yang, Chin-Fu Hsiao, et al.
Genes, Chromosomes & Cancer|August 13, 2011
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphomaSung-Hsin Kuo, Wen-Hui Weng, Zi-Hua Chen, et al.
The Journal of Pathology|November 23, 2016
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)Sung-Hsin Kuo, Hui-Jen Tsai, Chung-Wu Lin, et al.
The Oncologist|November 27, 2020
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid TumorsHer-Shyong Shiah, Nai-Jung Chiang, Chia-Chi Lin, et al.
Cancer Science|August 25, 2018
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumorHui-Jen Tsai, Weir-Torn Jiaang, Neng-Yao Shih, et al.
Cancer Medicine|March 31, 2021
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemiaHui-Jen Tsai, Hui-Hua Hsiao, Ya-Ting Hsu, et al.
International Journal of Cancer|February 10, 2010
Plasma decorin predicts the presence of esophageal squamous cell carcinomaI-Chen Wu, Deng-Chyang Wu, Chun-Chi Huang, et al.
Bone Marrow Transplantation|February 14, 2018
Stem cell transplantation for T-cell lymphomas in TaiwanYa-Ting Hsu, Hui-Jen Tsai, Jeffrey S Chang, et al.
Cancer Cell International|November 19, 2024
Cooperative participation of CagA and NFATc1 in the pathogenesis of antibiotics-responsive gastric MALT lymphomaHui-Jen Tsai, Kun-Huei Yeh, Chung-Wu Lin, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|August 12, 2016
BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid LeukemiaLi-Tzong Chen, Chiung-Tong Chen, Weir-Torn Jiaang, et al.
The Oncologist|June 21, 2024
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 studyHui-Jen Tsai, Shih-Hung Yang, Chin-Fu Hsiao, et al.
Genes, Chromosomes & Cancer|August 13, 2011
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphomaSung-Hsin Kuo, Wen-Hui Weng, Zi-Hua Chen, et al.
The Journal of Pathology|November 23, 2016
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)Sung-Hsin Kuo, Hui-Jen Tsai, Chung-Wu Lin, et al.
The Oncologist|November 27, 2020
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid TumorsHer-Shyong Shiah, Nai-Jung Chiang, Chia-Chi Lin, et al.
Cancer Science|August 25, 2018
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumorHui-Jen Tsai, Weir-Torn Jiaang, Neng-Yao Shih, et al.
Cancer Medicine|March 31, 2021
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemiaHui-Jen Tsai, Hui-Hua Hsiao, Ya-Ting Hsu, et al.
International Journal of Cancer|February 10, 2010
Plasma decorin predicts the presence of esophageal squamous cell carcinomaI-Chen Wu, Deng-Chyang Wu, Chun-Chi Huang, et al.
Bone Marrow Transplantation|February 14, 2018
Stem cell transplantation for T-cell lymphomas in TaiwanYa-Ting Hsu, Hui-Jen Tsai, Jeffrey S Chang, et al.
Cancer Cell International|November 19, 2024
Cooperative participation of CagA and NFATc1 in the pathogenesis of antibiotics-responsive gastric MALT lymphomaHui-Jen Tsai, Kun-Huei Yeh, Chung-Wu Lin, et al.
Pageof 7